Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

In regard to "Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer" (Int J Radiat Oncol Biol Phys 2011;81:669-676).

Schirmer MA, Wolff HA, Conradi LC, Christiansen H.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1058. doi: 10.1016/j.ijrobp.2011.10.062. No abstract available.

PMID:
22284030
2.

Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.

Hur H, Kang J, Kim NK, Min BS, Lee KY, Shin SJ, Keum KC, Choi J, Kim H, Choi SH, Lee MY.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):669-76. doi: 10.1016/j.ijrobp.2010.06.049. Epub 2010 Oct 6.

PMID:
20932673
3.

X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.

Lamas MJ, Duran G, Gomez A, Balboa E, Anido U, Bernardez B, Rana-Diez P, Lopez R, Carracedo A, Barros F.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):138-44. doi: 10.1016/j.ijrobp.2010.09.053. Epub 2010 Dec 16.

PMID:
21167658
4.
5.

Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.

Arrazubi V, Suárez J, Guerrero D, Gómez M, Viúdez A, Arias F, Balén E, Vera R.

Colorectal Dis. 2013 Apr;15(4):428-35. doi: 10.1111/codi.12009.

PMID:
22958523
6.

Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.

Jakob C, Liersch T, Meyer W, Baretton GB, Schwabe W, Häusler P, Kulle B, Becker H, Aust DE.

Am J Surg Pathol. 2006 Sep;30(9):1169-74. Erratum in: Am J Surg Pathol. 2006 Nov;30(11):1489.

PMID:
16931962
7.

p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.

Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P, Solomon MJ.

Dis Colon Rectum. 2003 Feb;46(2):192-202.

PMID:
12576893
9.

Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. In regard to MG Zampino et al. (Int J Radiat Oncol Biol Phys 2009;75:421-427).

Tunio MA, Hashmi AH.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1275; author reply 1275-6. doi: 10.1016/j.ijrobp.2009.11.046. No abstract available.

PMID:
20206024
10.

Polymorphisms in the thymidylate synthase gene predict response to 5-fluorouracil therapy in colorectal cancer.

Gibson TB.

Clin Colorectal Cancer. 2006 Jan;5(5):321-3. Review. No abstract available.

PMID:
16512989
11.

Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil.

Páez D, Paré L, Altés A, Sancho-Poch FJ, Petriz L, Garriga J, Monill JM, Salazar J, del Rio E, Barnadas A, Marcuello E, Baiget M.

J Cancer Res Clin Oncol. 2010 Nov;136(11):1681-9. doi: 10.1007/s00432-010-0826-7. Epub 2010 Feb 18.

PMID:
20165956
13.

Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil.

Fernández-Contreras ME, Sánchez-Prudencio S, Sánchez-Hernández JJ, García de Paredes ML, Gisbert JP, Roda-Navarro P, Gamallo C.

Int J Oncol. 2006 May;28(5):1303-10.

PMID:
16596248
14.

A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.

Terrazzino S, Agostini M, Pucciarelli S, Pasetto LM, Friso ML, Ambrosi A, Lisi V, Leon A, Lise M, Nitti D.

Pharmacogenet Genomics. 2006 Nov;16(11):817-24.

PMID:
17047490
15.

Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.

Stoehlmacher J, Goekkurt E, Mogck U, Aust DE, Kramer M, Baretton GB, Liersch T, Ehninger G, Jakob C.

Cancer Lett. 2008 Dec 18;272(2):221-5. doi: 10.1016/j.canlet.2008.07.008. Epub 2008 Aug 21.

PMID:
18722050
16.

Thymidylate synthase gene polymorphisms effecting 5-FU response in breast cancer patients.

Kumar K, Vamsy M, Jamil K.

Cancer Biomark. 2010;6(2):83-93. doi: 10.3233/CBM-2009-0121.

PMID:
20571234
17.

Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity.

Kim SR, Park CH, Park S, Park JO, Lee J, Lee SY.

Chemotherapy. 2010;56(4):313-7. doi: 10.1159/000320032. Epub 2010 Aug 13.

PMID:
20714149
18.

Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.

Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, Ajani J, Rich TA, Goswitz MS, Evetts PA, Allen PK, Lynch PM, Skibber JM.

Radiother Oncol. 1999 May;51(2):153-60.

PMID:
10435807

Supplemental Content

Support Center